PF-06263276

Biochem/physiol Actions

PF-06263276 is an inhibitor of the Janus kinase (JAK) enzymes 1, 2, 3 and tyrosine kinase 2 (TYK2). PF-06263276 has been investigated for the treatment of psoriasis.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Solubility Form Assay Price Quantity
3573751 PF-06263276 white to beige 100 SIGMA-ALDRICH DMSO: 5 mg/mL, clear
£410.89 (exc VAT) per 25MG
-
+
3573752 PF-06263276 white to beige 100 SIGMA-ALDRICH DMSO: 5 mg/mL, clear
£101.26 (exc VAT) per 5MG
-
+